Immutep IMMP
NASDAQ IMMP
$3.56 +0.10 (+2.89%)
As of: Nov 11, 2026 · 3:59 PM EST

Immutep (IMMP) Non Operating Interest Expenses (2016)

Updated

Immutep (IMMP) reported Non Operating Interest Expenses of -$48,162 for the year ended Jun 30, 2026, compared with -$23,746 a year earlier.

Analysis

Immutep (IMMP) Non Operating Interest Expenses (2016) Analysis & Trends

Dating back to the year ended Jun 30, 2009, Immutep's Non Operating Interest Expenses record includes 12 years.

  • The figure for the year ended Jun 30, 2026 ranks as the lowest annual Non Operating Interest Expenses since the year ended Jun 30, 2022.
  • According to Business Quant data, Non Operating Interest Expenses came in at -$23,746 in the year ended Jun 30, 2025, -$20,162 in the year ended Jun 30, 2024, -$13,635 in the year ended Jun 30, 2023 and -$66.2 billion in the year ended Jun 30, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 217.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -477.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 653.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 269.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Immutep 252.65 Mn 41.62 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2016 12,244.43
API Access

Immutep Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=IMMP&period=max&api_key=YOUR_API_KEY